Inter Parfums Q1
This article was originally published in The Rose Sheet
Executive Summary
Sales for the first quarter of fiscal year 2007 were up 20% over the prior-year period to $85.2 mil., Inter Parfums reports April 19. U.S. sales increased 19% to $9.6 mil. on the continued success of the Banana Republic bath, body and fragrance products. In May, more than 70 new bath and body products will debut in more than 150 Gap Body stores nationwide; a new Gap eau de toilette line will follow in Q3. The new products are scheduled to roll out to stores in late summer, continuing through the remainder of the year. In Europe, sales jumped 20% to $75.6 mil. on growth in all the major brands, as well as on the success of the Van Cleef & Arpels fragrances, which the firm officially took over on board Jan. 1...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.